S13. Down Syndrome Regression Disorder: New Frontiers in Biomarkers, Phenotypes, and Clinical Trials
Tracks
Room 1
| Friday, June 19, 2026 |
| 9:30 - 11:30 |
| Room 1 |
Speaker
Dr. Ryan Kammeyer
Crnic Institute For Down Syndrome Research
Title to be determined
Biography
Dr. Jonathan Douglas Santoro
Director of Neuroimmunology
Children's Hospital Los Angeles and the Keck School of Medicine of the University of Southern California
Title to be determined
Biography
Neetha Eduthan
Blood and CSF Biomarkers in DSRD
Biography
Dr Cathy Franklin
Director, QCEIDAH
The University Of Queensland
Patient Management and Monitoring Clinical Outcomes in DSRD
Biography
